DeMuth Peter 4
4 · Elicio Therapeutics, Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
DeMuth Peter
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-30+29,800→ 29,800 totalExercise: $5.03Exp: 2024-09-30→ Common Stock (29,800 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.